Phase II study of sorafenib and docetaxel in men with metastatic castration resistant prostate cancer (mCRPC)
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. P. Cetnar, M. A. Rosen, D. J. Vaughn, N. B. Haas, A. B. Troxel, H. Song, G. Adluru, K. T. Flaherty, P. J. O'Dwyer, R. K. Amaravadi
Institution: University of Pennsylvania
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2201256239
